Peptometry
416 posts

Peptometry
@peptometry
Peptometry is a peptide tracking app with a reconstitution calculator, inventory tracker, custom protocol builder, and daily logs for weight loss goals.






Seltorexant (JNJ-42847922 / MIN-202) is now available for laboratory and scientific research use at Kimera Chems. This compound is a selective orexin-2 receptor (OX2R) antagonist that has been the subject of extensive preclinical investigation for its effects on orexin signaling pathways. The orexin system regulates wakefulness, arousal, and related processes in mammalian physiology. OX2 receptor antagonists selectively block signaling at the OX2 subtype. In laboratory models, this selective blockade has been studied for its ability to modulate wake-promoting pathways without the broader receptor engagement characteristic of dual orexin receptor antagonists (DORAs). Within the orexin antagonist class, key pharmacological differences exist. Several dual orexin receptor antagonists (DORAs), which block both OX1 and OX2 receptors, have received regulatory approval for insomnia treatment in adults; examples include suvorexant, lemborexant, and daridorexant. These compounds produce combined effects on orexin-mediated signaling. In contrast, seltorexant is a selective OX2 receptor antagonist (2-SORA) with reported >100-fold preference for OX2 over OX1. This selectivity profile enables researchers to investigate OX2-specific contributions in controlled preclinical models, independent of OX1 modulation—an approach of interest for studies seeking to dissect receptor subtype roles in arousal and sleep-wake pathways. Development of seltorexant remains investigational. It is currently advancing through Phase 3 clinical trials for major depressive disorder with insomnia symptoms and related indications. Data from completed trials have been presented at scientific congresses. No regulatory approval has been granted for any clinical use. At Kimera Chems, seltorexant is supplied with third-party Certificate of Analysis (COA) documentation. It is offered exclusively for laboratory and scientific research purposes. It is not intended for human consumption, veterinary use, clinical application, or any therapeutic purpose. Researchers are responsible for ensuring compliance with all applicable institutional and regulatory requirements and for conducting their own due diligence. For specifications or COA requests, visit: kimerachems.co/product/seltor… #ResearchChemicals #Neuroscience #OrexinAntagonist #LaboratoryResearch







slept with mouthtape for the first time and couldn’t get rid of the feeling that i was being suffocated i think that’s a sign i need to continue sleeping taped up. and get nose strips








It's amazing all the fake info all these "Insiders" and fake " journalist" have been putting out for click bait. And what's more amazing is the people that actually believe it and run with it. Now all of you look like 🤡 trying to deflect and act like you don't remember saying it lol. Sometimes it's actually better to be right than first. If no major outlet is speaking on it don't believe the guy that's never sat at the table for these discussions. #SourcesBroTrustMe



The sign-stealing scandal continues to unfold, and fans demanding silence are infuriating. Your team cheated, and expecting everyone to forget is audacious. Xichigan's legacy is tarnished by fraud. #CFB #MichiganMan




Let's get the bad news out of the way: Vilon and Vesugen are going to be delayed as they came back 0-peptide, including everything else (nothing that we don't already have) I tried from that particular vendor. This is why we test, especially with new factories. Spoke to Freedom Diagnostics about the results and he said it's happening more than he's ever seen before. If you're buying site unseen without verification then you're going to get burned at some point. There's *always* someone cheaper. You pay us to take these losses and make sure someone reputable is responsible for you getting what you pay for.













